Investing

Proceeds from sale of other investments

Abbott Proceeds from sale of other investments remained flat by 0.0% to $750.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 89.3%, from $7.00M to $750.00K. Over 4 years (FY 2021 to FY 2025), Proceeds from sale of other investments shows a downward trend with a -55.6% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2020
Last reportedQ4 2025Feb 20, 2026

How to read this metric

Provides insight into the liquidation of non-core assets to generate liquidity or realize value.

Detailed definition

This captures cash proceeds from the sale of miscellaneous investments that do not fit into standard categories like deb...

Peer comparison

Company-specific; varies based on the diversity of the investment portfolio.

Metric ID: bac_proceeds_from_sale_of_other_investments

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$77.00M$152.00M$43.00M$28.00M$3.00M
YoY Change+97.4%-71.7%-34.9%-89.3%
Range$3.00M$152.00M
CAGR-55.6%
Avg YoY Growth-24.6%
Median YoY Growth-53.3%
Current Streak3 years decline

Frequently Asked Questions

What is Abbott's proceeds from sale of other investments?
Abbott (ABT) reported proceeds from sale of other investments of $750.00K in Q4 2025.
How has Abbott's proceeds from sale of other investments changed year-over-year?
Abbott's proceeds from sale of other investments decreased by 89.3% year-over-year, from $7.00M to $750.00K.
What is the long-term trend for Abbott's proceeds from sale of other investments?
Over 4 years (2021 to 2025), Abbott's proceeds from sale of other investments has grown at a -55.6% compound annual growth rate (CAGR), from $77.00M to $3.00M.
What does proceeds from sale of other investments mean?
Cash received from selling non-standard or miscellaneous investment assets.